Finance

Beta
Lists
524348:BOM
Aarti Drugs Ltd
₹378.00
-3.23%
(-12.60) 1D
May 29, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524348...
Open
₹391.10
High
₹393.65
Low
₹378.00
Mkt. cap
34.72B
Avg. vol.
8.75K
Volume
5.57K
Dividend
0.53%
Quarterly dividend
₹0.50
Ex-dividend date
Feb 9, 2026
P/E ratio
17.70
52-wk high
₹574.95
52-wk low
₹318.60
EPS
₹21.36
Shares outstanding
23.58M
No. of employees
1K
Open
₹391.10
High
₹393.65
Low
₹378.00
Mkt. cap
34.72B
Avg. vol.
8.75K
Volume
5.57K
Dividend
0.53%
Quarterly dividend
₹0.50
Ex-dividend date
Feb 9, 2026
P/E ratio
17.70
52-wk high
₹574.95
52-wk low
₹318.60
EPS
₹21.36
Shares outstanding
23.58M
No. of employees
1K
News stories
From sources across the web
About Aarti Drugs Ltd
CEOPrakash M. Patil
Employees1.28K
Founded1984
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.91B
6.53B
6.02B
7.20B
Cost of goods sold
3.73B
4.08B
3.87B
4.50B
Cost of revenue
3.73B
4.08B
3.87B
4.50B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
308.00M
330.70M
331.60M
322.80M
Operating expense
1.57B
1.76B
1.77B
1.91B
Total operating expenses
5.31B
5.85B
5.63B
6.42B
Operating income
596.70M
681.20M
383.20M
785.20M
Other non operating income
24.00K
-91.00K
16.00K
-45.00K
EBT including unusual items
511.12M
604.11M
290.32M
703.56M
EBT excluding unusual items
511.12M
604.11M
290.32M
703.56M
Income tax expense
-28.60M
152.50M
-115.20M
151.00M
Effective tax rate
-5.60%
25.24%
-39.68%
21.46%
Other operating expenses
1.12B
1.27B
1.26B
1.41B
Net income
539.10M
452.80M
405.40M
551.90M
Net profit margin
9.13%
6.94%
6.74%
7.66%
Earnings per share
-
4.95
-
-
Interest and investment income
-
-
-
-
Interest expense
-85.60M
-77.00M
-92.90M
-81.60M
Net interest expenses
-85.60M
-77.00M
-92.90M
-81.60M
Depreciation and amortization charges
147.20M
162.60M
179.50M
180.40M
EBITDA
736.15M
836.10M
515.81M
952.62M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more